Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors
This study is ongoing, but not recruiting participants.
Study NCT01315431   Information provided by Genta Incorporated

First Received on March 11, 2011.   Last Updated on July 23, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Solid Tumor
Additional conditions recognized in this trial
Neoplasms
Interventions listed in this trial
Tesetaxel plus capecitabine
Additional drug interventions recognized in this trial
Capecitabine
Fluorouracil
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Genta Incorporated


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services